GLOX THERAPEUTICS LIMITED
GLOX THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under SC760230, incorporated on 27 February 2023. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 3 years. Registered office address: G4 0RE Glasgow, the United Kingdom. Directors include DR MICHAEL STEPHEN MURRAY, DR PAUL NICKLIN, and PROFESSOR DANIEL WALKER. Associated with 4 related entities, including 11495328, METALLOBIO LIMITED, and 07201137. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
JOHN ARBUTHNOTT BUILDING STRATHCLYDE UNIVERSITY OF PHARMACY & BIOMEDICAL
161 CATHEDRAL STREET
G4 0RE GLASGOW
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | SC760230 | 2026-06-01 | open_in_new |